Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  International Immunology

• Publication date

  1998-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/INTIMM/10.12.1969PMID 9885918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells.

  1998cited by this paper
• Autoimmune Disease as a Consequence of Developmental Abnormality of a T Cell Subpopulation(T細胞発生過程における異常-胸腺摘出-による自己免疫病発症機序の解析)

  1997cited by this paper
• Transforming Growth Factor β (TGF-β)-dependent Inhibition of T Helper Cell 2 (Th2)-induced Autoimmunity by Self–Major Histocompatibility Complex (MHC) Class II–specific, Regulatory CD4+ T Cell Lines

  1997cited by this paper
• Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor.

  1997cited by this paper
• T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity.

  1997cited by this paper
• Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.

  1997cited by this paper
• A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

  1997cited by this paper
• Polymorphism of murine Fas ligand that affects the biological activity.

  1997cited by this paper
• A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells

  1996cited by this paper
• In vitro differentiation and commitment of CD4+ CD8+ thymocytes to the CD4 lineage, without TCR engagement.

  1996cited by this paper
• A Model for Developmentally Acquired Thymus‐Dependent Tolerance to Central and Peripheral Antigens

  1996cited by this paper
• T cell suppression in transplantation tolerance through linked recognition.

  1996cited by this paper
• Memory T cell development in the absence of specific antigen priming.

  1996cited by this paper
• Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation

  1996cited by this paper
• Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

  1995cited by this paper
• Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment.

  1995cited by this paper
• Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule

  1995cited by this paper
• Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

  1995cited by this paper
• CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

  1995cited by this paper
• NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function

  1995cited by this paper
• Induction of autoimmune disease in mice by germline alteration of the T cell receptor gene expression.

  1994cited by this paper
• Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.

  1994cited by this paper
• Anergic T cells as suppressor cells in vitro.

  1994cited by this paper
• Multiple levels of peripheral tolerance.

  1993cited by this paper
• Expression of two alpha chains on the surface of T cells in T cell receptor transgenic mice

  1993cited by this paper
• Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice

  1993cited by this paper
• Tolerance mechanism in experimental ovarian and gastric autoimmune diseases.

  1992cited by this paper
• CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

  1992cited by this paper
• Retinoic acids inhibit activation-induced apoptosis in T cell hybridomas and thymocytes.

  1992cited by this paper
• Reversal of in vitro T cell clonal anergy by IL-2 stimulation.

  1992cited by this paper
• Stigma variations: observations on suppressor T cells and leprosy.

  1992cited by this paper
• Molecular targets in pernicious anaemia.

  1991cited by this paper
• T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire

  1991cited by this paper
• Molecular Events in the T Cell‐Mediated Suppression of the Immune Response

  1991cited by this paper
• A Transgenic Approach to the Study of Peripheral T‐Cell Tolerance

  1991cited by this paper
• A novel subpopulation of CD45RA+ CD4+ T cells expressing IL-2 receptor alpha-chain (CD25) and having a functionally transitional nature into memory cells.

  1991cited by this paper
• Subsets of CD4+ T Cells and their Roles in the Induction and Prevention of Autoimmunity

  1991cited by this paper
• Autoimmune diseases: the failure of self tolerance.

  1990cited by this paper
• Restricted expression of p55 interleukin 2 receptor (CD25) on normal T cells.

  1990cited by this paper
• Tolerance in transgenic mice expressing major histocompatibility molecules extrathymically on pancreatic cells.

  1990cited by this paper
• Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease

  1990cited by this paper
• Adoptive transfer of autoimmune diabetes and thyroiditis to athymic rats.

  1990cited by this paper
• Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo.

  1990cited by this paper
• OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset [published erratum appears in J Exp Med 1991 Apr 1;173(4):1037]

  1990cited by this paper
• Clonal anergy induced in mature Vβ6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells

  1989cited by this paper
• A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines

  1989cited by this paper
• Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice

  1988cited by this paper
• Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes.

  1988cited by this paper
• Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. I. Requirement of Lyt-1 dull L3T4 bright normal T cells for the induction of thyroiditis.

  1988cited by this paper
• Ligand-receptor interactions required for commitment to the activation of the interleukin 2 gene.

  1987cited by this paper
• Antigen presentation by chemically modified splenocytes induces antigen- specific T cell unresponsiveness in vitro and in vivo

  1987cited by this paper
• Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease

  1985cited by this paper
• The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells.

  1984cited by this paper
• Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin

  1983cited by this paper
• T cell growth factor: parameters of production and a quantitative microassay for activity.

  1978cited by this paper
• [Autoimmunity and autoimmune diseases].

  1970cited by this paper
• Immunological Tolerance

  1956cited by this paper
• Transforming Growth Factor (cid:98) (TGF- (cid:98) )-dependent Inhibition of T Helper Cell 2 (Th2)-induced Autoimmunity by Self–Major Histocompatibility Complex (MHC) Class II–specific, Regulatory CD4 (cid:49) T Cell Lines

  year unknowncited by this paper

• Purification, Phenotypic and Functional Analyses of Regulatory T Cells in Autoimmunity.

  2026cites this paper
• Tumor microenvironment heterogeneity and immunotherapy resistance: multidimensional modulation strategies for precision breakthroughs

  2026cites this paper
• ADAM9 supports regulatory T cell stability through TGF-β-SMAD signaling and is reduced in systemic lupus erythematosus.

  2026cites this paper
• Treg cell plasticity as a driver of inflammation in spondyloarthritis and psoriasis

  2025cites this paper
• Assessing Human Treg Suppression at Single-Cell Resolution Using Mass Cytometry

  2025cites this paper
• ECM29/proteasome-mediated self-antigen generation by CNS-resident neuroglia promotes regulatory T cell activation.

  2025cites this paper
• The Role of Fc-like Receptor 3 in the Pathophysiology of Rheumatoid Arthritis

  2025cites this paper
• Generating functionally stable and antigen-specific Treg cells from effector T cells for cell therapy of inflammatory diseases.

  2025cites this paper
• Pan‑immune‑inflammatory values predict survival in patients after radical surgery for non‑metastatic colorectal cancer: A retrospective study

  2025cites this paper
• Regulatory T cells suppress GM-CSF-producing T helper cells via IL-2 modulation to restrain immunopathology.

  2025cites this paper
• Therapeutic targeting of cell death-immune crosstalk in cancer to rewire the tumor immune microenvironment

  2025cites this paper
• Transforming cancer immunotherapy: Overcoming immunosuppression in tumors via gene silencing techniques based on nanoparticles

  2025cites this paper
• T cell receptor precision editing of regulatory T cells for celiac disease.

  2025cites this paper
• A Semi-Mechanistic Mathematical Model of Immune Tolerance Induction to Support Preclinical Studies of Human Monoclonal Antibodies in Rats

  2025cites this paper
• Regulatory T cell therapy for Graft-versus-Host Disease

  2025cites this paper
• Regulatory T Cells in Tumor Microenvironment: Therapeutic Approaches and Clinical Implications

  2025cites this paper
• Treg cells augment self-tolerance during infection

  2025cites this paper
• Immunomodulatory mechanisms of the gut microbiota and metabolites on regulatory T cells in rheumatoid arthritis

  2025cites this paper
• Extracellular Vesicle-Based Strategies for Tumor Immunotherapy

  2025cites this paper
• Generation of antigen-specific and functionally stable Treg cells from effector/memory T cells for cell therapy of immunological diseases

  2025cites this paper
• Durable response to CAR T is associated with elevated activation and clonotypic expansion of the cytotoxic native T cell repertoire

  2025cites this paper
• Single cell suppression profiling of human regulatory T cells

  2025cites this paper
• ER stress induced mitochondrial dysfunction drives Treg instability in coronary artery disease

  2025cites this paper
• Cytokine-driven cancer immune evasion mechanisms.

  2025cites this paper
• IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy

  2024cites this paper
• Research Progress of Regulatory T Cell-Mediated Immune Escape in Cancer

  2024cites this paper
• Regulatory T cells: Genetic modifications and impact on disease treatment

  2024cites this paper
• Regulatory T cells as a possible new target in epilepsy?

  2024cites this paper
• Targeting the dynamic transcriptional landscape of Treg subpopulations in pancreatic ductal adenocarcinoma: Insights from single-cell RNA sequencing analysis with a focus on CTLA4 and TIGIT.

  2024cites this paper
• Regulatory role of CD39 and CD73 in tumor immunity

  2024cites this paper
• PPARδ restrains the suppression function of intra-tumoral Tregs by limiting CIITA-MHC II expression

  2024cites this paper
• Controlled WASp activity regulates the proliferative response for Treg cell differentiation in the thymus

  2024cites this paper
• CD137-expressing Regulatory T Cells in Cancer and Autoimmune Diseases.

  2024cites this paper
• Different evasion strategies in multiple myeloma

  2024cites this paper
• Regulatory CD4+ T cells: permanent or temporary suppressors of immunity

  2024cites this paper
• Role of Regulatory T Cells in Intracerebral Hemorrhage

  2024cites this paper
• Differential proteins from EVs identification based on tandem mass tags analysis and effect of Treg-derived EVs on T-lymphocytes in COPD patients

  2024cites this paper
• DGKα and ζ Deficiency Causes Regulatory T-Cell Dysregulation, Destabilization, and Conversion to Pathogenic T-Follicular Helper Cells to Trigger IgG1-Predominant Autoimmunity

  2024cites this paper
• Down-regulation of TCF7 and LEF1 is a key determinant of tumor-infiltrating regulatory T cell function.

  2024cites this paper
• Autoimmune and Neoplastic Outcomes After the mRNA Vaccination: The Role of T Regulatory Cell Responses

  2024cites this paper
• The effects of tumor-derived supernatants (TDS) on cancer cell progression: A review and update on carcinogenesis and immunotherapy.

  2024cites this paper
• Diverse roles of dendritic cell and regulatory T cell crosstalk in controlling health and disease.

  2024cites this paper
• TNFSF9 Is Associated with Favorable Tumor Immune Microenvironment in Patients with Renal Cell Carcinoma Who Are Treated with the Combination Therapy of Nivolumab and Ipilimumab

  2024cites this paper
• Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells

  2024cites this paper
• Distinct characteristics of unique immunoregulatory canine non-conventional TCRαβpos CD4negCD8αneg double-negative T cell subpopulations

  2024cites this paper
• Th17/Treg cell balance in patients with papillary thyroid carcinoma: a new potential biomarker and therapeutic target

  2024cites this paper
• C8Mab-21: A novel anti-human CCR8 monoclonal antibody for flow cytometry

  2024cites this paper
• Regulatory T cells in lung disease and transplantation

  2023cites this paper
• Phenotypic and Functional Studies of Human Treg Cell Subpopulations.

  2023cites this paper
• A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammation

  2023cites this paper
• Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer

  2023cites this paper
• Regulatory T Cells in the Pathogenesis of Graves’ Disease

  2023cites this paper
• Immunological mechanisms of tolerance: Central, peripheral and the role of T and B cells

  2023cites this paper
• Acquisition of suppressive function by conventional T cells limits anti-tumor immunity upon Treg depletion

  2023cites this paper
• Cross-Activation of Regulatory T Cells by Self Antigens Limits Self-Reactive and Activated CD8+ T Cell Responses

  2023cites this paper
• A mAb to SIRPα downregulates the priming of naive CD4 + T cell in Primary immune thrombocytopenia.

  2023cites this paper
• Engineering antigen-specific tolerance to an artificial protein hydrogel

  2023cites this paper
• Regulatory T cells in autoimmune kidney diseases and transplantation

  2023cites this paper
• Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches

  2023cites this paper
• The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy

  2023cites this paper
• Cytokine Gene Polymorphisms in Patients with Chronic Inflammatory Demyelinating Polyneuropathy

  2023cites this paper
• Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective

  2023cites this paper
• Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses

  2023cites this paper
• Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial

  2023cites this paper
• Emerging hallmark of gliomas microenvironment in evading immunity: a basic concept

  2023cites this paper
• Immunomodulatory effect of locoregional therapy in the tumor microenvironment.

  2023cites this paper
• The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4+ T cells resembling iTreg

  2023cites this paper
• T regulatory Function and Modification for Future Application

  2023cites this paper
• CD8+iTregs mediate the protective effect of rapamycin against graft versus host disease in a humanized murine model.

  2023cites this paper
• The microsomal prostaglandin E synthase-1/PGE2 axis induces recovery from ischemia via recruitment of regulatory T cells.

  2022cites this paper
• Breast cancers co-opt normal mechanisms of tolerance to promote immune evasion and metastasis.

  2022cites this paper
• Changes in the proportion of regulatory T cell subpopulations during menstrual cycle and early pregnancy

  2022cites this paper
• Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity

  2022cites this paper
• Citrullination: A modification important in the pathogenesis of autoimmune diseases.

  2022cites this paper
• Migration and homeostasis of regulatory T cells in rheumatoid arthritis

  2022cites this paper
• Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice

  2022cites this paper
• Double Negative T Regulatory Cells: An Emerging Paradigm Shift in Reproductive Immune Tolerance?

  2022cites this paper
• CD24 is expressed on FoxP3+ regulatory T cells and regulates their function.

  2022cites this paper
• Transforming growth factor–β1 in regulatory T cell biology

  2022cites this paper
• Hyaluronan Synthase 3 is Protective After Cardiac Ischemia-Reperfusion by preserving the T cell Response.

  2022cites this paper
• Expression of CD127 Suppresses T Regulatory Cells in Psoriasis

  2022cites this paper
• Targeting Tregs in Tumors

  2022cites this paper
• Leptin Deficiency May Influence the Divergence of Cell-Mediated Immunity Between Lepromatous and Tuberculoid Leprosy Patients

  2022cites this paper
• T-Cell Mediated Immunity in Merkel Cell Carcinoma

  2022cites this paper
• Understanding the functional inflammatory factors involved in therapeutic response to immune checkpoint inhibitors for pan-cancer

  2022influential citation
• Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease

  2022cites this paper
• Chemokine Receptor-Targeted Therapies: Special Case for CCR8

  2022cites this paper
• Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progression

  2021cites this paper
• Role of CD4+CD25+FOXP3+ TReg cells on tumor immunity

  2021cites this paper
• Butyric Acid Protects Against Renal Ischemia–Reperfusion Injury by Adjusting the Treg/Th17 Balance via HO-1/p-STAT3 Signaling

  2021cites this paper
• Targeting NF‐κB c‐Rel in regulatory T cells to treat corneal transplantation rejection

  2021cites this paper
• Low-Dose Vitamin D3 Supplementation Does Not Affect Natural Regulatory T Cell Population but Attenuates Seasonal Changes in T Cell-Produced IFN-γ: Results From the D-SIRe2 Randomized Controlled Trial

  2021cites this paper
• Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells

  2021cites this paper
• Hot or Cold: Bioengineering Immune Contextures into In Vitro Patient-Derived Tumor Models.

  2021cites this paper
• An Agent-Based Model of T Helper Cell Fate Decisions in the Thymus

  2021cites this paper
• Determination of a CD4+CD25+ Foxp3+T cells subset in Egyptian Colorectal Cancer Patients.

  2021cites this paper
• Treg-Resistant Cytotoxic CD4+ T Cells Dictate T Helper Cells in Their Vicinity: TH17 Skewing and Modulation of Proliferation

  2021cites this paper
• Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications

  2021cites this paper
• CTLA-4 in Regulatory T Cells for Cancer Immunotherapy

  2021cites this paper
• Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance.

  2021cites this paper